/
Toolkit for research and development of paediatric antiretroviral drugs and formulations Toolkit for research and development of paediatric antiretroviral drugs and formulations

Toolkit for research and development of paediatric antiretroviral drugs and formulations - PowerPoint Presentation

luanne-stotts
luanne-stotts . @luanne-stotts
Follow
344 views
Uploaded On 2018-11-21

Toolkit for research and development of paediatric antiretroviral drugs and formulations - PPT Presentation

Module 10 Pharmacovigilance Background definitions Timeline of pharmacovigilance for a drug from development premarket to postmarketing use Burden of adverse drug reactions in children Number of pharmacoepidemiological safety studies in children Osokogu et al 2016 ID: 731494

antiretroviral pharmacovigilance solutions therapy pharmacovigilance antiretroviral therapy solutions studies countries income middle challenges children drug development

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Toolkit for research and development of ..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Toolkit for research and development of paediatric antiretroviral drugs and formulationsSlide2

Module 10:PharmacovigilanceSlide3

Background – definitionsSlide4

Timeline of pharmacovigilance for a drug from development (pre-market) to post-marketing useSlide5

Burden of adverse drug reactions in childrenSlide6

Number of pharmacoepidemiological safety studies in children (Osokogu et al, 2016)Slide7

Importance of pharmacovigilance in context of expanded antiretroviral therapySlide8

Challenges of antiretroviral therapy pharmacovigilance in low- and middle-income countries (1/2)Slide9

Challenges of antiretroviral therapy pharmacovigilance in low- and middle-income countries (2/2)Slide10

Solutions (1/3)Slide11

Solutions (2/3)Slide12

Solutions (3/3)Slide13

Case studiesSlide14

SummarySlide15

Key considerationsSlide16

Acknowledgements